Hanwha Investment & Securities Predicts Korean Power Company's Q4 Earnings Will Exceed Expectations

Reporter Kim Jisun / approved : 2025-01-15 07:37:29
  • -
  • +
  • 인쇄

Photo = Yonhap news

 

[Alpha Biz= Kim Jisun] Hanwha Investment & Securities analyzed that Korea Electric Power Corporation's (KEPCO) Q4 earnings will likely exceed market consensus. They maintained their "Buy" rating and target price of 33,000 KRW.

The firm attributed the positive earnings to the continued impact of the industrial electricity rate hike implemented last October, along with an increase in nuclear power generation and lower-than-expected System Marginal Price (SMP). Hanwha expects that KEPCO's operating profit for the full year 2024 will be 9.15 trillion KRW, with net profit at 4 trillion KRW, marking a full turnaround from the losses of the previous three years.

For Q4 2024, Hanwha estimated KEPCO's revenue and operating profit to increase by 4.2% and 67.6% year-over-year, respectively, to 23.5 trillion KRW and 3.2 trillion KRW. The operating profit estimate surpasses the market consensus by 23.8%, which was around 2.6 trillion KRW.

Hanwha's researcher, Song, projected that KEPCO’s profit improvement will remain strong in the short term. He stated that the company’s ability to repay debt and resume dividends will likely speed up due to the increased level of expected profits. However, he noted that expectations for additional electricity rate hikes should be tempered, and that freezing the fuel cost adjustment factor could be the best course of action for achieving rate increase effects.

 

 

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

주요기사

SK hynix and Naver Cloud Join Forces to Accelerate Next-Generation AI Memory Solutions2025.09.11
HD Hyundai Heavy Industries Strike Clash Leaves Union Member Injured2025.09.11
Chartered Korean Air Flight to Repatriate Over 300 Koreans Detained at Georgia Battery Plant; Industry Fears Multi-Billion Losses Amid Construction Halt2025.09.11
Chong Kun Dang Chairman Transfers Entire Stake in Kyungbo Pharmaceutical to Children, Expands IT Subsidiary Portfolio2025.09.11
Harim Holdings to Acquire Entire Harim USA Stake from Subsidiary Farmsco2025.09.11
뉴스댓글 >